Poor Tuberculosis Treatment Outcomes Associated with Older Age, Previous Treatment, HIV and Drug Resistance at Seven Hospitals in Indonesia
Abstract
Abstract
Indonesia is a high burden country for tuberculosis (TB), multidrug-resistant (MDR) TB, and TB-HIV. We aimed to determine factors associated with poor TB treatment outcomes. A hospital-based TB Registry at seven referral hospitals in Java and Bali included data from patients aged ≥15 years who were diagnosed with TB from 1 January 2014 - 31 December 2015. The factors were assessed by logistic regression. From 2,051 TB patients, 1,180 (57.5%) were male and median age was 38 years (IQR 27-50 years), 452 (22%) had previous TB treatment history, 1,447 (70.6%) had pulmonary TB, 216 (10.5%) TB-HIV, 296 (14.4%) TB-DM and 248 (12.1%) were resistant to ≥1 anti-TB drug. Treatment outcome was unknown for 135 (6.6%) subjects and 1,137 (55.4%) who were still on treatment. Among the 779 with available outcome, 358 (46%) were treatment success, 248 (31.8%) transferred out, 112 (14.4%) defaulted, 46 (5.9%) died and 15 (1.9%) failed. After controlling other factors, poor TB treatment was associated with age ≥38 years (p=0.003; aOR 1.58; 95% CI 1.2-2.1), previous history of TB treatment (p<0.001; aOR 2.55; 95% CI 1.5-4.2) and resistance to ≥1 anti-TB drug (p<0.001; aOR 11.66; 95% CI 3.8-36.1). Mortality was associated with previous history of TB treatment (p=0.003; aOR 3.87; 95% CI 1.7-9.6), TB-HIV (p=0.001; aOR 10.43; 95% CI 4.2-26.1), and resistance to ≥1 anti-TB drug (p=0.001; aOR 9.48; 95% CI 2.6-34.0). Treatment in TB patients with older age, history of previous TB treatment, HIV, and drug resistance should be closely monitored.
Keywords: Indonesia, tuberculosis, treatment outcome
Abstrak
Indonesia adalah negara dengan beban tinggi untuk tuberkulosis (TB), TB resisten obat (MDR) dan TB-HIV. Analisis ini bertujuan untuk menentukan faktor yang terkait dengan luaran pengobatan TB yang buruk. Registri TB berbasis rumah sakit di tujuh rumah sakit rujukan di Jawa dan Bali mencakup data dari pasien berusia ≥15 tahun yang didiagnosis TB dari 1 Januari 2014 - 31 Desember 2015. Faktor-faktor tersebut dinilai dengan regresi logistik. Dari 2.051 pasien TB, 1.180 (57,5%) laki-laki dan median usia 38 tahun (IQR 27-50 tahun), 452 (22%) memiliki riwayat pengobatan TB sebelumnya, 1.447 (70,6%) memiliki TB paru, 216 (10,5%) TB-HIV, 296 (14,4%) TB-DM dan 248 (12,1%) resisten terhadap ≥1 obat anti-TB. Luaran pengobatan TB tidak diketahui untuk 135 (6,6%) subjek dan 1.137 (55,4%) yang masih dalam pengobatan. Di antara 779 dengan luaran pengobatan diketahui, 358 (46%) pengobatan berhasil, 248 (31,8%) pindah, 112 (14,4%) putus pengobatan, 46 (5,9%) meninggal dan 15 (1,9%) gagal. Setelah dikontrol terhadap faktor lain, luaran pengobatan TB yang buruk dikaitkan dengan usia ≥38 tahun (p = 0,003; aOR 1,58; 95% CI 1,2-2,1), riwayat pengobatan TB sebelumnya (p <0,001; aOR 2,55; 95% CI 1,5-4,2) dan resistansi terhadap ≥1 obat anti-TB (p <0,001; aOR 11,66; 95% CI 3,8-36,1). Kematian dikaitkan dengan riwayat pengobatan TB sebelumnya (p = 0,003; aOR 3,87; 95% CI 1,7-9,6), TB-HIV (p = 0,001; aOR 10,43; 95% CI 4,2-26,1), dan resistansi terhadap ≥1 anti -TB obat (p = 0,001; aOR 9,48; 95% CI 2,6-34,0). Pengobatan pada pasien TB dengan usia yang lebih tua, riwayat pengobatan TB sebelumnya, HIV dan resistansi obat harus dipantau secara ketat.
Kata kunci: Indonesia, tuberkulosis, luaran pengobatan
References
Saxena A, Horby P, Amuasi J, Aagaard N, Kohler J, Gooshki ES, et al. Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel.. BMC Med Ethics. 2019;20(1):29. doi:10.1186/s12910-019-0366-x
Trinh QM, Nguyen HL, Nguyen VN, Nguyen TV, Sintchenko V, Marais BJ. Tuberculosis and HIV co-infection-focus on the Asia-Pacific region. Int J Infect Dis. 2015;32:170-8. doi:10.1016/j.ijid.2014.11.023
Alemu A, Bitew ZW, Worku T. Poor treatment outcome and its predictors among drug-resistant tuberculosis patients in Ethiopia: A systematic review and meta-analysis. Int J Infect Dis. 2020;98:420-439. doi:10.1016/j.ijid.2020.05.087
Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, et al. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis. PLoS medicine. 2018;15(7):e1002591. doi:10.1371/journal.pmed.1002591
Harris RC, Grandjean L, Martin LJ, Miller AJ, Nkang JE, Allen V, et al. The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review. BMC Infect Dis. 2016;16:193. doi:10.1186/s12879-016-1524-0
Ragan EJ, Kleinman MB, Sweigart B, Gnatienko N, Parry CD, Horsburgh CR, et al. The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2020;24(1):73-82. doi:10.5588/ijtld.19.0080
Singh A, Prasad R, Kushwaha RAS, Srivastava R, Giridhar BH, Balasubramanian V, et al. Treatment outcome of multidrug-resistant tuberculosis with modified DOTS-plus strategy: A 2 years' experience. Lung India. 2019;36(5):384-92. doi:10.4103/lungindia.lungindia_475_18
Wen Y, Zhang Z, Li X, Xia D, Ma J, Dong Y, et al. Treatment outcomes and factors affecting unsuccessful outcome among new pulmonary smear positive and negative tuberculosis patients in Anqing, China: a retrospective study. BMC Infect Dis. 2018;18(1):104. doi:10.1186/s12879-018-3019-7
Tok PSK, Liew SM, Wong LP, Razali A, Loganathan T, Chinna K, et al. Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study. PLoS One. 2020;15(4):e0231986. doi:10.1371/journal.pone.0231986
Nanzaluka FH, Chibuye S, Kasapo CC, Langa N, Nyimbili S, Moonga G, et al. Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: a secondary analysis of routine surveillance data. The Pan African medical journal. 2019;32:159. doi:10.11604/pamj.2019.32.159.18472
Melese A, Zeleke B. Factors associated with poor treatment outcome of tuberculosis in Debre Tabor, northwest Ethiopia. BMC Res Notes. 2018;11(1):25. doi:10.1186/s13104-018-3129-8
Shewade HD, Gupta V, Satyanarayana S, Kharate A, Murali L, Deshpande M, et al. Are we missing ‘previously treated’ smear-positive pulmonary tuberculosis under programme settings in India? A cross-sectional study. F1000Res. 2019;8:338. doi:10.12688/f1000research.18353.2
Rifat M, Hall J, Oldmeadow C, Husain A, Hinderaker SG, Milton AH. Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh. BMJ Open. 2015;5(9):e008273. doi:10.1136/bmjopen-2015-008273
Mohd Shariff N, Shah SA, Kamaludin F. Previous treatment, sputum-smear nonconversion, and suburban living: The risk factors of multidrug-resistant tuberculosis among Malaysians. Int J Mycobacteriol. 2016;5(1):51-8. doi:10.1016/j.ijmyco.2015.11.001
Holden IK, Lillebaek T, Seersholm N, Andersen PH, Wejse C, Johansen IS. Predictors for Pulmonary Tuberculosis Treatment Outcome in Denmark 2009–2014. Sci Rep. 2019;9(1):12995. doi:10.1038/s41598-019-49439-9
Singanayagam A, Manalan K, Connell DW, Chalmers JD, Sridhar S, Ritchie AI, et al. Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2016;20(12):1653-60. doi:10.5588/ijtld.16.0159
Takhar RP, Saxena A, Khangarot S, Garg R, Bansiwal B, Shringi KN. Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India. European Respiratory Journal. 2019;54. doi:10.1183/13993003.congress-2019.PA4639
Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, et al. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLOSMedicine.2018;15(7):e1002595.doi:10.1371/journal.pmed.1002595
